Chadi A. Hage, MD
Associate Professor of Clinical Medicine
Dr. Hage is ABIM certified in Infectious Diseases, Pulmonary Medicine and Critical Care Medicine with strong interest in lung immunology as well as pulmonary infections and fungal diseases. His research and clinical activities are in the fileds of fungal infections, lung transplant, ECMO and transplant critical Care. Dr. Hage is well published on endemic mycoses (Histoplasmosis and Blastomycosis), fungal infections of the immunocompromised patients, as well as outcomes of lung transplants.
Lung Transplant Outcomes
Pulmonary Fungal Infections; Aspergillosis, Histoplasmosis, Blastomycosis
Biomarkers for the Rapid Diagnosis of Fungal infections and respiratory tract infections
Infections in the Immunocompromised host
Evaluation of two new enzyme immunoassay reagents for diagnosis of histoplasmosis in a cohort of clinically characterized patients.
Evaluation of Alemtuzumab Versus Basiliximab Induction: A Retrospective Cohort Study in Lung Transplant Recipients.
Histoplasmosis complicating tumor necrosis factor-a blocker therapy: a retrospective analysis of 98 cases.
Histoplasmosis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): multicenter study of outcomes and factors associated with relapse.
Low-positive histoplasma antigen results in the MVista assay should not be assumed to be false positive.
Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States.
Development of a highly sensitive and specific blastomycosis antibody enzyme immunoassay using Blastomyces dermatitidis surface protein BAD-1.
Investigation of the efficacy of micafungin in the treatment of histoplasmosis using two North American strains of Histoplasma capsulatum.
Histoplasma antigen clearance during treatment of histoplasmosis in patients with AIDS determined by a quantitative antigen enzyme immunoassay.
Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy.
Corticosteroids for blastomycosis-induced ARDS: a report of two patients and review of the literature.
A 30-year-old man with HIV infection and fever with cough 2 months after starting antiretroviral therapy.
Cryptococcal glucoxylomannan does not exhibit cross-reactivity in the MVista Histoplasma antigen enzyme immunoassay.
Cytometric analysis of BAL T cells labeled with a standardized antibody cocktail correlates with immunohistochemical staining.
Diagnosis of pulmonary histoplasmosis and blastomycosis by detection of antigen in bronchoalveolar lavage fluid using an improved second-generation enzyme-linked immunoassay.
Macrophages exposed to lymphotropic and monocytotropic HIV induce similar CTL responses despite differences in productive infection.
American Board of Internal Medicine - Infectious Disease
American Board of Internal Medicine - Critical Care Medicine